Intensity Therapeutics, Inc. Awarded Cooperative Research And Development Agreement From National Cancer Institute

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WESTPORT, Conn.--(BUSINESS WIRE)--Intensity Therapeutics, Inc. (private) announced today that the Company established a cooperative research and development agreement (CRADA), with the National Institute of Health’s National Cancer Institute (NCI) Vaccine Branch.

Help employers find you! Check out all the jobs and post your resume.

Back to news